FGFR2 and Apert syndrome: Prenatal diagnosis of Apert syndrome has transitioned from isolated anomaly detection to a molecularly integrated paradigm, where recognition of the sonographic triad is synergistically enhanced by fetal MRI biomarkers and rapid FGFR2 sequencing.